Emylif 50 mg, film orodispersibile

7680689150017 CH-68915 Film
Emylif 50 mg, film orodispersibile
Emylif 50 mg, film orodispersibile
Emylif 50 mg, film orodispersibile
1 / 3
google

Article details

Package size
56
Selling units
56
Measure
Stück
Galenic form
Film
Galenic group
Vaginal-Produkte

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/03/2025
Patient information leaflet
Français
07/03/2025
Patient information leaflet
Italien
07/03/2025
Summary of Product Characteristics
Allemand
07/03/2025
Summary of Product Characteristics
Français
07/03/2025
Summary of Product Characteristics
Italien
07/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.89 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
0.06 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 212.05
Specialties list
Yes
Generic
No
SL addition date: 01/04/2024

Authorization holder

Zambon Svizzera SA

6814 Cadempino

Authorization information

Swissmedic authorization number
68915
Drug name
Emylif, film orodispersibile
Galenic form
SCHMF
ATC Code
N07XX02
Authorization status
Z
Dispensing category
B
First authorization
17/11/2023
Authorization expiration date
16/11/2028
IT Number
01.99.0.
Domain
Human medicine
Field of application
Amyotrophische Lateralsklerose (ALS)

Package details

Description (FR)
EMYLIF film orodisp 50 mg sach 56 pce
Description (DE)
EMYLIF Schmelzfilm 50 mg Btl 56 Stk
Market launch
17/11/2023
Narcotic (BTM)
No